Carl L Gordon insider trades: Electra Therapeutics (ETRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Carl reports to the SEC
and 21 more companies
Open-market buys and sales
60 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | ETRA | ↑ Buy | 472,571 | $7.63 | $3.6M | Indirect | Nov 5, 2026 (0d) |
| Sep 28, 2026 | ADRX | ↑ Buy | 950,000 | $17.00 | $16.1M | Indirect | Sep 30, 2026 (2d) |
| Sep 21, 2026 | ETRA | ↑ Buy | 1,333,333 | $15.00 | $20.0M | Indirect | Sep 23, 2026 (2d) |
| Aug 10, 2026 | BLSM | ↑ Buy | 625,000 | $16.00 | $10.0M | Indirect | Aug 12, 2026 (2d) |
| Jul 27, 2026 | SCTX | ↑ Buy | 1,000,000 | $15.00 | $15.0M | Indirect | Jul 29, 2026 (2d) |
| Apr 9, 2025 | CMPX | ↓ Sell | 3,571,428 | $1.59 | $5.7M | Indirect | Apr 11, 2025 (2d) |
| Feb 18, 2025 | MBX | ↑ Buy | 190,672 | $10.60 | $2.0M | Indirect | Feb 19, 2025 (1d) |
| Sep 16, 2024 | MBX | ↑ Buy | 500,000 | $16.00 | $8.0M | By OrbiMed Private Investments VII, LP | Sep 17, 2024 (1d) |
| Sep 16, 2024 | MBX | ↑ Buy | 250,000 | $16.00 | $4.0M | By OrbiMed Genesis Master Fund, L.P. | Sep 17, 2024 (1d) |
| Aug 13, 2024 | KROS | ↓ Sell | 250,000 | $44.01 | $11.0M | Indirect | Aug 15, 2024 (2d) |
| Jul 16, 2024 | TERN | ↓ Sell | 56,164 | $10.00 | $562K | Indirect | Jul 17, 2024 (1d) |
| May 15, 2024 | PHGE | ↓ Sell | 24,344 | $0.38 | $9K | Indirect | May 20, 2024 (5d) |
| Jan 30, 2024 | AVBP | ↑ Buy | 222,222 | $18.00 | $4.0M | Indirect | Jan 31, 2024 (1d) |
| Jan 25, 2024 | ACET | ↑ Buy | 3,125,000 | $2.40 | $7.5M | Indirect | Jan 26, 2024 (1d) |
| Jul 17, 2023 | THRX | ↑ Buy | 479,932 | $3.05 | $1.5M | Indirect | Jul 19, 2023 (2d) |
| Jun 27, 2023 | ACET | ↑ Buy | 875,000 | $2.09 | $1.8M | Indirect | Jun 29, 2023 (2d) |
| May 5, 2023 | KNTE | ↑ Buy | 1,377,473 | $2.80 | $3.9M | Indirect | May 8, 2023 (3d) |
| May 2, 2023 | KNTE | ↑ Buy | 1,346,342 | $2.61 | $3.5M | Indirect | May 2, 2023 (0d) |
| Feb 27, 2023 | PHGE | ↑ Buy | 348,000 | $0.24 | $85K | Indirect | Mar 17, 2023 (18d) |
| Dec 23, 2022 | TERN | ↑ Buy | 137,931 | $7.25 | $1000K | Indirect | Dec 28, 2022 (5d) |
| Nov 8, 2022 | CMPX | ↑ Buy | 402,000 | $3.21 | $1.3M | Indirect | Nov 10, 2022 (2d) |
| Nov 7, 2022 | THRX | ↑ Buy | 192,000 | $5.21 | $1.0M | Indirect | Nov 9, 2022 (2d) |
| Aug 16, 2022 | TERN | ↑ Buy | 3,690,000 | $2.42 | $8.9M | Indirect | Aug 18, 2022 (2d) |
| May 13, 2022 | CMPX | ↑ Buy | 192,516 | $2.18 | $420K | Indirect | May 13, 2022 (0d) |
| May 10, 2022 | CMPX | ↑ Buy | 125,359 | $1.57 | $197K | Indirect | May 10, 2022 (0d) |
| Feb 15, 2022 | KNTE | ↑ Buy | 195,700 | $10.17 | $2.0M | Indirect | Feb 15, 2022 (0d) |
| Jan 21, 2022 | THRX | ↑ Buy | 158,417 | $9.97 | $1.6M | Indirect | Jan 21, 2022 (0d) |
| Jan 13, 2022 | THRX | ↑ Buy | 44,717 | $9.90 | $443K | Indirect | Jan 13, 2022 (0d) |
| Nov 4, 2021 | CMPX | ↑ Buy | 5,357,143 | $3.50 | $18.8M | Indirect | Nov 8, 2021 (4d) |
| Oct 12, 2021 | THRX | ↑ Buy | 562,500 | $16.00 | $9.0M | By OrbiMed Private Investments VII, LP | Oct 14, 2021 (2d) |
| Oct 12, 2021 | THRX | ↑ Buy | 62,500 | $16.00 | $1.0M | By OrbiMed Genesis Master Fund, L.P. | Oct 14, 2021 (2d) |
| Mar 30, 2021 | ORIC | ↓ Sell10b5-1 | 103,424 | $23.48 | $2.4M | Indirect | Mar 31, 2021 (1d) |
| Mar 26, 2021 | ORIC | ↓ Sell10b5-1 | 112,298 | $24.53 | $2.8M | Indirect | Mar 26, 2021 (0d) |
| Mar 23, 2021 | ORIC | ↓ Sell10b5-1 | 32,940 | $26.21 | $863K | Indirect | Mar 23, 2021 (0d) |
| Mar 18, 2021 | ORIC | ↓ Sell10b5-1 | 66,202 | $27.95 | $1.9M | Indirect | Mar 18, 2021 (0d) |
| Mar 15, 2021 | ORIC | ↓ Sell10b5-1 | 238,282 | $30.54 | $7.3M | Indirect | Mar 15, 2021 (0d) |
| Feb 9, 2021 | TERN | ↑ Buy | 475,000 | $17.00 | $8.1M | Indirect | Feb 9, 2021 (0d) |
| Dec 2, 2020 | KNTE | ↑ Buy | 750,000 | $20.00 | $15.0M | Indirect | Dec 4, 2020 (2d) |
| Jun 19, 2020 | NONE | ↑ Buy | 1,455,132 | $5.00 | $7.3M | Indirect | Jun 23, 2020 (4d) |
| Apr 24, 2020 | ORIC | ↑ Buy | 281,250 | $16.00 | $4.5M | Indirect | Apr 28, 2020 (4d) |
| Apr 13, 2020 | KROS | ↑ Buy | 375,200 | $16.00 | $6.0M | Indirect | Apr 13, 2020 (0d) |
| Jun 24, 2019 | PRVL | ↑ Buy | 882,352 | $17.00 | $15.0M | Indirect | Jun 26, 2019 (2d) |
| Apr 22, 2019 | TPTX | ↑ Buy | 360,000 | $18.00 | $6.5M | By OrbiMed Private Investments VI, LP | Apr 24, 2019 (2d) |
| Feb 11, 2019 | ALEC | ↑ Buy | 411,700 | $19.00 | $7.8M | Indirect | Feb 11, 2019 (0d) |
| Nov 20, 2017 | ASNS | ↑ Buy | 500,000 | $10.00 | $5.0M | Indirect | Nov 20, 2017 (0d) |
| Jun 27, 2016 | SELB | ↑ Buy | 550,000 | $14.00 | $7.7M | Indirect | Jun 29, 2016 (2d) |
| May 11, 2016 | NTLA | ↑ Buy | 250,000 | $18.00 | $4.5M | Indirect | May 11, 2016 (0d) |
| Sep 4, 2012 | AMRN | ↓ Sell | 233,700 | $14.43 | $3.4M | Indirect | Sep 5, 2012 (1d) |
| Jul 27, 2012 | AMRN | ↓ Sell | 366,300 | $14.61 | $5.4M | Indirect | Jul 30, 2012 (3d) |
| Jun 19, 2012 | AMRN | ↓ Sell | 617,100 | $12.94 | $8.0M | Indirect | Jun 19, 2012 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ETRA insiders
Open-market trades in the last 12 months
About Carl L Gordon's insider trades
Carl L Gordon is a director at Electra Therapeutics (ETRA). Since Dec 2, 2005, Carl has reported 39 open-market purchases worth $237.7M and 21 sales worth $136.2M on SEC Form 4. In the last 12 months: 5 buys ($64.8M).
5 sales (11% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (51 filings), conversions (20 filings), shares returned to the company (7 filings), other transactions (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ETRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.